HotSpot is a private biotech and an investment of Atlas Venture. The company recently raised $100M in a Series C financing and has a platform addressing a number of major disease states including oncology and rare diseases.
In late 2020, Occam recruited Eva Jack, previously CBO of Mersana Therapeutics, to be the COO in a role that would also encompass Business Development.
